Treatment of hyperlipidemia with 15-keto-prostaglandin compounds

Details Treatment of hyperlipidemia with 15-keto-prostaglandin compounds Treatment of hyperlipidemia with 15-keto-prostaglandin compounds

1992-06-15

1993-08-10

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514824, A61K 3119, A61K 31557

Patent

active

052349543

ABSTRACT:
A method for treatment of hyperlipemia which comprises administering, to a subject in need of such treatment, a 15-keto-prostaglandin compound in an amount, effective in decreasing lipid concentration in the blood.

REFERENCES:
patent: 4157341 (1979-06-01), Bindra et al.
patent: 4278688 (1981-07-01), Hayashi et al.
patent: 4459310 (1984-07-01), Dajani
CA 109:67747m Syntex (U.S.A.), Inc., 1986.
Anggard, Acta physiol. scand, 1966, 66, pp. 509-510.
Robert, et al., Prostaglandins, vol. 11, No. 5, May 1976 pp. 809-828.
Chemical Abstract, vol. 109, 1988-corresponding to JPA 122624.
Chemical Abstract, vol. 110, 1989, 110:891f-corresponding to JPA 286924.
Pharmaceuticals, vol. 110, 1989, p. 431.
Chemical Abstracts, vol. 84, No. 21, 1975, Abstract No. 145224v.

Affiliated with

Also associated with

Rating

Treatment of hyperlipidemia with 15-keto-prostaglandin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hyperlipidemia with 15-keto-prostaglandin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hyperlipidemia with 15-keto-prostaglandin compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1725553